Opicapone

🧮 Dose calculator

Parkinson's disease · Regimen source: FDA Ongentys · 2.1

• • No food 1 h before and at least 1 h after. Moderate hepatic impairment: 25 mg; severe: avoid. FDA Ongentys · 2.1FDA Ongentys · 2.2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ongentys · 8.1

  “Risk Summary There are no adequate data on the developmental risk associated with use of ONGENTYS in pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Ongentys · 8.2

  “Risk Summary There are no data on the presence of opicapone in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Ongentys · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Ongentys · 8.5

  “No dose adjustment is required for elderly patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.